Eluvixtamab (AMG-330)
Revision as of 22:24, 7 December 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Chemotherapeutic" to "")
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3